Skip to content
thestock.space

Manipal Health Enterprises (MANIPALHOS) had a P/E of 133.6× on 6 Nov 2026, above the industry P/E of 47.7×, and the shares are 21% below their 52-week high. It earns ROCE of 9.8% and ROE of 9.2%. Debt is 1.46× equity. It is a mid-cap company with a market cap of ₹85,065 Cr, ranked 3rd of 40 Medical Care Facilities companies by market cap; the shares fell 3.0% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹657.25
Day high
₹657.35
Day low
₹643.10
Prev. close
₹657.25
Volume
3.6 L

Health check

1 fair · 4 to check
  • ReturnsBehind

    −3.0% over a year, better than 2 of 7 peers.

  • Price tagPricier

    P/E 133.6 vs industry 47.7.

  • Growthn/a

    Not enough yearly results to measure.

  • ProfitabilityWeak

    ROCE 9.8% vs peer median 11.9%.

  • Balance sheetFair

    Debt 1.46× equity, interest covered 1.8×, Piotroski 6 of 9.

  • Red flags2 to check

    P/E of 133.6 against an industry P/E of 47.7.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Medical Care Facilities

39 listed peers. Screen the industry

Mid cap

₹85,065 Cr, #3 of 40 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹11,189 Cr · profit ₹874 Cr
Market cap
₹85,065 Cr
Mid cap
P/E
133.6
Industry 47.7
Price to book
9.05
Peers 8.06
Dividend yield
0.00%
ROE
9.2%
Peers 12.8%
ROCE
9.8%
Peers 11.9%
Debt to equity
1.46
Debt ₹12,863 Cr
EPS (TTM)
₹4.84
Face value ₹2
OPM (TTM)
17.8%
Net margin 7.8%
Sales growth
+38.1%
Latest quarter vs a year ago
Profit growth
−7.5%
Latest quarter vs a year ago
Price to sales
7.60
EV/EBITDA 33.6

Strengths and risks

Strengths

  • Quarterly sales up 38.1% on a year ago.
  • Positive operating cash flow in each of the last 3 years.

Risks to check

  • P/E of 133.6 against an industry P/E of 47.7.
  • Interest coverage of only 2.3×.

Derived automatically from reported figures. Not a recommendation.

About Manipal Health Enterprises

Manipal Health Enterprises Limited operates hospitals in India. The company offers services, such as multi-specialty tertiary and quaternary care through its network of hospitals. Its services include accident and emergency care, cancer care, cardiology, organ transplants, obstetrics and gynaecology, neurology, nephrology, orthopaedics, proctology, rheumatology, and urology. The company also offers medical services, including robotic spine surgery,…

Headquarters
Bengaluru
Employees
24,240
Sector
Healthcare
ISIN
INE459N01021
Website
manipalhospitals.com

Price range

52 weeks

₹597.00₹815.00

Today

₹643.10₹657.35
Avg volume (3M)
13.1 L
1-year return
minus 3.0%
From 52-week high
minus 20.7%

Analyst consensus

9 analysts
BuyMean target ₹818.33 plus 26.5%

Target range, with today’s price

Low ₹730.00High ₹880.00

Today’s price ₹646.70 is below the lowest analyst target.

Consensus from Yahoo Finance. Not a recommendation.

Peers · Medical Care Facilities

Compare with peersScreen the whole industry
Company
APOLLOHOSPApollo Hospitals Enterprise8,446.00plus 0.90%1,21,44154.011.4519.2%22.5%15.4%14.8%33.3%0.24%plus 7.2%
MAXHEALTHMax Healthcare Institute934.00plus 0.21%90,90966.18.0312.6%12.8%26.8%22.4%9.3%0.21%minus 18.1%
MANIPALHOSManipal Health Enterprises646.70minus 1.61%85,065133.69.059.8%9.2%17.8%––0.00%minus 3.0%
ASTERDMAster DM Quality Care713.15minus 0.89%62,09290.78.069.4%9.7%17.4%15.7%−3.0%0.42%plus 4.5%
FORTISFortis Healthcare766.90minus 6.45%57,89855.75.5211.9%10.4%22.2%13.3%20.9%0.13%minus 19.6%
NHNarayana Hrudayalaya1,903.00minus 0.65%38,65044.77.7311.4%19.1%18.5%20.5%9.9%0.24%plus 4.7%
MEDANTAGlobal Health1,387.60minus 0.15%37,26460.48.6315.0%15.2%22.1%17.2%19.5%0.04%plus 11.2%
KIMSKrishna Institute of Medical Sciences723.00minus 1.10%30,366138.512.878.1%11.0%19.8%21.3%−10.5%0.00%plus 2.0%
Median of 7 peers–−0.65%57,89860.48.0611.9%12.8%19.8%17.2%9.9%0.21%4.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrJun 25Jun 26
2,2383,091
1,6512,354
586737
26.2%23.8%
48.474.6
132293
141187
−18.4−15.5
344315
26.2%22.8%
250232
1.901.76

Sep 25, Dec 25, Mar 26 not reported by the data source.

Profit & loss

Yearly, ₹ crore
ROE
9.2%
Net profitSelect a row below to chart it
₹ CrMar 2024Mar 2025Mar 2026
6,0799,26410,936
–+52.4%+18.0%
4,3587,0158,260
1,7212,2482,675
28.3%24.3%24.5%
−39.6146212
4051,1421,154
397507680
−135−13.3−93.6
745732960
28.4%26.9%28.6%
594513655
–minus 13.7%+27.7%
4.523.904.98

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2024Mar 2025Mar 2026
75.677.1236
3,9405,7438,190
5,13011,90112,863
1,6733,7233,575
10,81921,44424,865
5,0247,9109,031
49.4700805
116295291
1,3853,0972,811
4,2449,44311,926
10,81921,44424,865

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2024Mar 2025Mar 2026
1,3891,5702,078
−870−2,658−7,037
−2509044,954
268−184−3.9
−332−1,054−1,316
1,057516762

Shareholding pattern

Source: NSE filings
72.1%
promoters
  • Promoters72.08%
  • Public27.92%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202672.08%27.92%0.00
4 Aug 202672.08%27.92%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you